In parallel, both MS and COPD involve dysregulated T cell responses, particularly Th17 polarization and autoreactive CD4+ T cells, which may contribute to sustained autoimmunity and target-organ injury [175,176]. The gene discussed is CD4; the disease is chronic obstructive pulmonary disease.